9-Methoxy-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde

Catalog No. :
ACZBGM142
CAS No. :
951796-54-6
Molecular Formula :
C11H12O4
Molecular Weight :
208.21

IUPAC Name:9-methoxy-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde

9-Methoxy-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$111.00Login to see priceInquiryInquiry
250mg98%$147.00Login to see priceInquiryInquiry
1g98%$370.00Login to see priceInquiryInquiry
5g98%$1108.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-Methoxy-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde
IUPAC Name9-methoxy-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde
MDL No.MFCD11052245
Molecular FormulaC11H12O4
Molecular Weight208.21
SMILESO=CC1=CC(OC)=C2OCCCOC2=C1
InChI KeyCPVGOFHSNRVEQX-UHFFFAOYSA-N
Synonym9-Methoxy-3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde;6-methoxy-3,4-dihydro-2H-1,5-benzodioxepine-8-carbaldehyde;9-methoxy-3,4-dihydro-2H-1,5-benzodioxepine-7-carbaldehyde;2H-1,5-Benzodioxepin-7-carboxaldehyde, 3,4-dihydro-9-methoxy-
CAS No.951796-54-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZBGM142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZBGM142 route product structure diagram
    ACZBGM142951796-54-6
Inquiry

2. ACZBGM142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZBGM142 route product structure diagram
    ACZBGM142951796-54-6
Inquiry

Comments (0)